Saturday, April 30, 2011

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA


In continuation of my update on drugs discovery on  rheumatoid arthritis, 

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA..
Posted by https://www.med-chemist.com at 8:47 AM
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)